First experience with a ready to use solution for remote monitoring of patients suffering from heart failure in France - 09/01/21
, B. Diebold 11Riassunto |
Background |
Heart failure (HF) is associated with a high mortality rate and recurrent hospitalizations.
Purpose |
To present the first data of the patients using the innovative solution Satelia® Cardio (NP Medical/WeHealth™ Digital Medicine).
Method |
Satelia® Cardio is a HF patient management solution with a remote monitoring system and a therapeutic guidance by dedicated nurse phone platform, supported by ETAPES Program. The system is accessible from any devices, requiring no installation, and the use is possible by non-connected patients. After the inclusion, the patient is contacted by the nurse, he then receives an SMS alert on regular basis, with a link leading to a web page to answer 7 questions, and to give his current body weight. Satelia algorithm is based on this signs,their variability, and the weight. In case of worsening of symptoms, the cardiologist will be notified.
Results |
124 centers (200 cardiologists) are using Satelia® Cardio with 1832 HF patients monitored in the last 18 months. The patients, mean age of 72 years (19-97) are predominantly males (69%), and mostly NYHA II/III (68%/30%). The adherence to the system is very good (81%) with 86% of patients still monitored (N=1569). The main reasons for stopping are related to the occurrence of death (105/263) or non-fatal events (71/263), or patient decision (87/263). Over the period of analysis, the HF patients answered to 46 637 questionnaires, generating 2429 alerts transmitted to the referent cardiologists. Since Covid-19 lockdown, more than 600 patients have been monitored with the solution.
Conclusion |
Patient management solution with a remote monitoring system is key to improving the follow-up of HF patients. The solution Satelia® Cardio is an easy way to use a web application to monitor HF patients, accepted by the patients with a low rate of premature discontinuation. A further step will be to initiate studies to assess the clinical impact of such remote monitoring solution in HF.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 13 - N° 1
P. 26 - gennaio 2021 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
